Regarding preferred agent for inducing oocyte maturation in COS, 80% of respondents preferred a standard hCG trigger, and 20% preferred GnRH agonist trigger (a modification to traditional protocols that has been proposed to reduce the risk of ovarian hyperstimulation syndrome in women with cancer undergoing COS for FP [11,16,17]). This evidence concerns the gene GNRH1 and cancer.